Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G protein-coupled receptor 158 (GPR158) is a member of the class C GPCR superfamily predominantly expressed in the central nervous system, where it serves as an atypical metabotropic receptor for glycine[2][5][1]. GPR158 controls synapse formation and neuronal excitability, and is implicated in mood regulation, cognition, and stress response[5][7]. Unlike classic class C GPCRs, GPR158 does not directly couple to conventional G proteins, but instead recruits and regulates the RGS7-Gβ5 complex, which modulates downstream signaling by acting on Gi/o proteins to control cAMP levels[1][2][5]. Recent studies show GPR158 is activated by glycine, with taurine acting as a weaker partial agonist, and there is emerging evidence for a role in peripheral endocrine regulation and potential involvement in glucocorticoid-induced ocular hypertension[1][2][3]. No approved therapeutics currently target GPR158.
Glycine binds to GPR158, altering its conformation and the associated RGS7-Gβ5 complex, resulting in regulation of cAMP production and downstream signaling pathways. Taurine acts as a partial agonist at this receptor, but with lower potency than glycine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein-coupled receptor 158 (GPR158).